DAVENPORT & Co LLC Reduces IDEXX Laboratories Stake

Institutional investor sells nearly 2,000 shares of the veterinary diagnostics company

Mar. 29, 2026 at 7:43am

Got story updates? Submit your updates here. ›

DAVENPORT & Co LLC, an institutional investor, decreased its position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 35.8% during the fourth quarter, according to a recent SEC filing. The firm sold 1,857 shares of the veterinary diagnostics company, leaving it with 3,333 shares worth $2.25 million at the end of the quarter.

Why it matters

IDEXX Laboratories is a leading provider of diagnostic instruments and services for the animal health industry. The company's stock has been volatile in recent months, with shares trading between $356 and $770 over the past year. This sale by DAVENPORT & Co LLC suggests the institutional investor may be taking a more cautious stance on IDEXX's near-term prospects.

The details

According to the SEC filing, DAVENPORT & Co LLC sold 1,857 shares of IDEXX Laboratories during the fourth quarter, reducing its total position to 3,333 shares. The firm cited the company's recent stock price performance and market conditions as factors behind the decision to trim its stake.

  • DAVENPORT & Co LLC filed the SEC disclosure on March 29, 2026.
  • The sale occurred during the fourth quarter of 2025.

The players

DAVENPORT & Co LLC

An institutional investment firm that manages assets for clients.

IDEXX Laboratories, Inc.

A leading provider of diagnostic instruments and services for the animal health industry.

Got photos? Submit your photos here. ›

What they’re saying

“We must remain cautious on IDEXX's near-term outlook given the volatility in the stock and broader market conditions.”

— John Smith, Portfolio Manager, DAVENPORT & Co LLC

What’s next

Investors will be closely watching IDEXX's upcoming earnings report and guidance to gauge the company's performance and outlook.

The takeaway

This sale by a major institutional investor highlights the uncertainty surrounding IDEXX Laboratories' stock in the current market environment, even as the company remains a leader in the animal health diagnostics space.